Table 4.
Variable | Treatment outcome | Crude OR [95% CI] | Adjusted OR [95% CI] | |
---|---|---|---|---|
Improved (125; 57.6%) | Unimproved (92; 42.4%) | |||
Sex | ||||
Male | 83 (38.25) | 39 (17.97) | 1 | 1 |
Female | 42 (19.35) | 53 (24.42) | 2.686 [1.541–4.681]∗∗ | 2.919 [1.527–5.279]∗∗ |
Residence | ||||
Urban | 74 (34.01) | 51 (23.51) | 1 | 1 |
Rural | 51 (23.50) | 41 (18.89) | 1.166 [0.677–2.010] | 0.812 [0.380–1.734] |
Disease duration | ||||
Less than two years | 41 (18.89) | 51 (23.50) | 1 | 1 |
More than two years | 84 (15.47) | 41 (18.89) | 0.392 [0.225–1.684] | 0.249 [0.122–1.508] |
Distance | ||||
<2 hours | 94 (43.32) | 59 (27.19) | 1 | 1 |
≥2 hours | 31 (14.29) | 33 (15.21) | 1.333 [0.49–2.686] | 1.367 [0.603–3.099] |
Other psychiatric illnesses | ||||
Yes | 68 (43.31) | 57 (26.26) | 1 | 1 |
No | 57 (26.26) | 35 (16.13) | 1.365 [0.789–2.363] | 0.824 [0.414–1.642] |
Naranjo score | ||||
Possible | 10 (4.60) | 9 (4.15) | 1 | Ref |
Probable | 91 (41.93) | 77 (35.48) | 0.940 [0.363–2.432] | 0.898 [0.303–2.669] |
Level of adherence | ||||
Optimal | 62 (28.57) | 31 (14.28) | 0.37 [0.110–5.379]∗ | 0.432 [0.201–0.909]∗ |
Suboptimal | 63 (29.03) | 61 (28.11) | 1 | 1 |
Severity of ADR | ||||
Moderate | 86 (39.63) | 64 (29.49) | 1 | 1 |
Sever | 14 (6.45) | 22 (10.14) | 2.112 [1.003–4.444]∗ | 2.133 [0.912–4.990] |
∗Statistically significant at 0.05. ∗∗Significant at 0.01.